As healthcare professionals, it is crucial to understand the intricacies of Parkinson's disease, a neurodegenerative disorder impacting millions worldwide. This article aims to provide a comprehensive overview of the condition, its pathophysiology, diagnosis, and management.
Parkinson's disease is characterized by the progressive loss of dopaminergic neurons in the substantia nigra, leading to the classic motor symptoms of tremor, rigidity, and bradykinesia. Non-motor symptoms such as cognitive impairment and mood disorders often precede motor symptoms, reflecting the multisystemic nature of the disease.
Diagnosis is primarily clinical, based on the presence of cardinal motor symptoms and supported by response to dopaminergic therapy. Neuroimaging techniques such as DaTSCAN can provide supportive evidence, but are not routinely required. Early diagnosis is challenging due to the non-specific nature of initial symptoms.
Management is symptomatic, aiming to improve quality of life. Pharmacotherapy with levodopa remains the mainstay of treatment. Dopamine agonists, MAO-B inhibitors and deep brain stimulation are other therapeutic options. Non-pharmacological interventions such as physiotherapy and occupational therapy play a significant role in managing disability.
Research is underway to develop disease-modifying therapies. Novel approaches such as gene therapy and stem cell transplantation are being explored. Understanding the genetic and environmental risk factors can pave the way for preventive strategies.
Parkinson's disease is a complex, multisystem disorder with significant impact on patients' lives. As healthcare professionals, a comprehensive knowledge of its pathophysiology, diagnosis, and management is essential. With ongoing research, we can hope for more effective therapies in the future.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation